InvestorsHub Logo
Followers 28
Posts 12075
Boards Moderated 0
Alias Born 01/02/2003

Re: biotech_researcher post# 130

Friday, 09/13/2019 9:28:42 AM

Friday, September 13, 2019 9:28:42 AM

Post# of 1203
from the 2nd CC (listen to the HC Wainwright presentation on the website to for further clarification);

and then really working with our partner GE to target first radiologists, second gastrohepatologist, and then third, people focus on metabolism that is associated with liver disease. People like endocrinologist and internal medicine.

So, I feel very good about having a lot of good first, second and third line targets identified by ourselves and with GE’s help that we can go to immediately.

We’re building relationship. We’re continuing and working with our partner, GE to identify potential targets

So, our goal is to have those early adopters in key markets in Germany and Switzerland, and France, elsewhere and in the U.S. to mention also what I’ve discussed, we’re partnering with GE and GE is going to help us target those GE ultrasound users. So that’s a great way for us to knock on the door of a GE customer with a GE sales rep. But I don’t plan to build out a massive ENDRA sales force.

"The Investors's Chief Problem--and even his worst enemy--is likely to be himself"
---Benjamin Graham

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NDRA News